07:43:23 18/09/2026 pm IST
5-day change
1st Jan Change
0.003600 USD
+2.86%
0.00%
+5.88%
5 minutes 15 minutes 30 minutes Hour Day Week Month
Candlestick Close OHLC Mountain
08/25/08
Protext Mobility, Inc. Announces J. M. K. Nkosi as Member of Advisory Board
CI
02/22/02
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update
CI
29/21/29
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility
CI
19/19/19
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.
CI
19/18/19
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.
CI
23/17/23
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc
CI
04/17/04
Protext Mobility, Inc. to Conduct Human Clinical Trial with Its Product Phytofare Catechin Complex
CI
27/17/27
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.
CI
07/17/07
Protext Mobility, Inc. Engages in the Development of Pharmaceutical Applications for the Highly Bioavailable Phytofare®
CI
31/16/31
Plandai SA completed the acquisition of ProText Mobility, Inc. in a reverse merger transaction.
CI
23/16/23
Plandai SA agreed to acquire ProText Mobility, Inc. in a reverse merger transaction.
CI
1 day +2.86%
Current month -5.26%
1 month -8.86%
3 months -34.55%
6 months -53.00%
Current year +5.88%
1 week
0
0
1 month
0
0
Current year
0
0.01
1 year
0
0.01
3 years
0
0.01
5 years
0
0.02
10 years
0
0.02
Manager
Title Age Since
Chief Executive Officer
-
-
President
-
05/09/2001
Director
Title Age Since
Chairman
-
05/09/2001
Director/Board Member
-
05/09/2001
Date
Insider
Type
Main position
Quantity
% Market Cap.
Importance
20/05/26
Buy
Founder
52,09,05,768
5.9253%
Protext Mobility, Inc. is a biotech company developing a hemp/cannabidiol (CBD) - cannabis medicines platform for the legal cannabis industry, using live plant extraction processes and technologies. The Company engages in the research, testing and development of bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications using proprietary live plant extraction technology. The Company's subsidiaries include Plandai Biotechnology, Cannabis Biosciences, Inc., and RSAMMD Acquisitions LLC.
Date
Price
Change
Volume
18/26/18
$0.003 600
+2.86%
17,84,352
17/26/17
$0.003500
-2.78%
92,23,884
16/26/16
$0.003600
+2.86%
44,81,161
15/26/15
$0.003500
-2.78%
35,48,657
14/26/14
$0.003600
0.00%
94,47,423
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-6pm CET
DAILY FREE LIMIT REACHED
To continue browsing, Sign up!
Personal watchlists and screeners
Access the "Discovery" Stock Screener (covering 30,000 companies)
Create your free account
Become a member and join over 1 million active investors
Already have an account?
Log in
Select your edition
All financial news and data tailored to specific country editions
